Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
Measurement of 47Calcium absorption was performed on eleven women with post-menopausal osteoporosis. The study was repeated after 10 days treatment with 1 microgram daily of 1,25(OH)2D3. These patients showed a statistically significant improvement of fractional calcium absorption that was inversely correlated to the basal values. The prompt improvement of the intestinal calcium transport in post-menopausal osteoporotic women, a few days after the administration of physiological doses of 1,25(OH)2D3, suggests that these patients synthesize inappropriately small amounts of 1,25(OH)2D3 because of their oestrogen deficiency. This could be an important pathogenetic factor in post-menopausal osteoporosis, as the efficiency of the adaptation of calcium absorption to low calcium intakes is dependent on 1,25(OH)2D3.
D000042:Absorption; D002118:Calcium / Q000378:metabolism*; D002132:Calcium Radioisotopes; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007408:Intestinal Absorption; D008593:Menopause; D010024:Osteoporosis / Q000188:drug therapy / Q000378:metabolism*
D002132:Calcium Radioisotopes; D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D002118:Calcium